These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26546933)

  • 1. [The Emeritus Dinosaur's viewpoint - The road to hell of gene therapists is paved with POC].
    Kaplan JC
    Med Sci (Paris); 2015 Nov; 31 Spec No 3():41-4. PubMed ID: 26546933
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic Applications of CRISPR/Cas for Duchenne Muscular Dystrophy.
    Wong TWY; Cohn RD
    Curr Gene Ther; 2017; 17(4):301-308. PubMed ID: 29173172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for Duchenne muscular dystrophy: AAV leads the way.
    Judge LM; Chamberlain JS
    Acta Myol; 2005 Dec; 24(3):184-93. PubMed ID: 16629052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From the smallest virus to the biggest gene: marching towards gene therapy for duchenne muscular dystrophy.
    Duan D
    Discov Med; 2006 Jun; 6(33):103-8. PubMed ID: 17234143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myodys, a full-length dystrophin plasmid vector for Duchenne and Becker muscular dystrophy gene therapy.
    Duan D
    Curr Opin Mol Ther; 2008 Feb; 10(1):86-94. PubMed ID: 18228186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of immunosuppression in gene- and cell-based treatments for duchenne muscular dystrophy.
    Arruda VR
    Mol Ther; 2007 Jun; 15(6):1040-1. PubMed ID: 17510638
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic therapeutic approaches for Duchenne muscular dystrophy.
    Foster H; Popplewell L; Dickson G
    Hum Gene Ther; 2012 Jul; 23(7):676-87. PubMed ID: 22647146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in the use of gene therapy to treat Duchenne muscular dystrophy.
    Jarmin S; Kymalainen H; Popplewell L; Dickson G
    Expert Opin Biol Ther; 2014 Feb; 14(2):209-30. PubMed ID: 24308293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of trans-splicing adeno-associated viral vectors for Duchenne muscular dystrophy gene therapy.
    Lai Y; Li D; Yue Y; Duan D
    Methods Mol Biol; 2008; 433():259-75. PubMed ID: 18679629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cautious welcome for gene editing of Duchenne muscular dystrophy in animal model.
    Hawkes N
    BMJ; 2016 Jan; 351():h7033. PubMed ID: 26729900
    [No Abstract]   [Full Text] [Related]  

  • 11. A New Kid on the Playground of CRISPR DMD Therapy.
    Duan D
    Hum Gene Ther Clin Dev; 2017 Jun; 28(2):62-64. PubMed ID: 28609189
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac Myoediting Attenuates Cardiac Abnormalities in Human and Mouse Models of Duchenne Muscular Dystrophy.
    Atmanli A; Chai AC; Cui M; Wang Z; Nishiyama T; Bassel-Duby R; Olson EN
    Circ Res; 2021 Sep; 129(6):602-616. PubMed ID: 34372664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors.
    Blankinship MJ; Gregorevic P; Chamberlain JS
    Mol Ther; 2006 Feb; 13(2):241-9. PubMed ID: 16361117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Codon optimization of the microdystrophin gene for Duchene muscular dystrophy gene therapy.
    Athanasopoulos T; Foster H; Foster K; Dickson G
    Methods Mol Biol; 2011; 709():21-37. PubMed ID: 21194019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral vector-mediated gene therapies.
    Hollinger K; Chamberlain JS
    Curr Opin Neurol; 2015 Oct; 28(5):522-7. PubMed ID: 26263476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CRISPR Way to Think about Duchenne's.
    Calos MP
    N Engl J Med; 2016 Apr; 374(17):1684-6. PubMed ID: 27119241
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase I study of dystrophin plasmid-based gene therapy in Duchenne/Becker muscular dystrophy.
    Romero NB; Braun S; Benveniste O; Leturcq F; Hogrel JY; Morris GE; Barois A; Eymard B; Payan C; Ortega V; Boch AL; Lejean L; Thioudellet C; Mourot B; Escot C; Choquel A; Recan D; Kaplan JC; Dickson G; Klatzmann D; Molinier-Frenckel V; Guillet JG; Squiban P; Herson S; Fardeau M
    Hum Gene Ther; 2004 Nov; 15(11):1065-76. PubMed ID: 15610607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Study Cites Immune Reaction to High Adeno-Associated Virus Dose in Explaining Duchenne Muscular Dystrophy Trial Death.
    Philippidis A
    Hum Gene Ther; 2023 Jul; 34(13-14):588-591. PubMed ID: 37462951
    [No Abstract]   [Full Text] [Related]  

  • 19. Core Concept: Human artificial chromosomes offer insights, therapeutic possibilities, and challenges.
    Dance A
    Proc Natl Acad Sci U S A; 2017 Sep; 114(37):9752-9754. PubMed ID: 28899976
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic engineering: In vivo genome editing - growing in strength.
    Koch L
    Nat Rev Genet; 2016 Mar; 17(3):124. PubMed ID: 26781811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.